Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Moody National Bank Trust Division grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 17.6% in ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS – Research Report), Quanterix ...

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) had its target price hoisted by equities researchers at Bank of ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Walgreens, like other companies in the retail pharmacy space, has struggled with challenges related to low reimbursement and ...

These four dividend payers are poised to post solid fourth-quarter results and continue to provide way above-average passive ...

In December, word spread that Walgreens Boots Alliance Inc. (Nasdaq: WBA) was reportedly considering selling itself to the PE firm Sycamore Partners. A ...

Management’s Discussion and Analysis of Financial Condition and Results of Operations," it was noted that as of November 30, ...

After a dreadful 2024 that saw its stock lose more than 60% of its value, 2025 has started off as a better year for Walgreens ...

Bank of America Securities analyst Allen Lutz reiterated a Sell rating on Walgreens Boots Alliance (WBA – Research Report) today and set a ...